Compare CSV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | HUMA |
|---|---|---|
| Founded | 1991 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.6M | 236.0M |
| IPO Year | 1996 | N/A |
| Metric | CSV | HUMA |
|---|---|---|
| Price | $42.31 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $59.00 | $10.13 |
| AVG Volume (30 Days) | 66.5K | ★ 4.2M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ 3.09 | N/A |
| Revenue | ★ $409,658,000.00 | $1,571,000.00 |
| Revenue This Year | $3.81 | N/A |
| Revenue Next Year | $3.37 | $698.97 |
| P/E Ratio | $13.70 | ★ N/A |
| Revenue Growth | ★ 1.07 | N/A |
| 52 Week Low | $35.51 | $1.04 |
| 52 Week High | $49.41 | $5.66 |
| Indicator | CSV | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 45.11 | 37.60 |
| Support Level | $42.79 | $1.04 |
| Resistance Level | $44.45 | $1.17 |
| Average True Range (ATR) | 0.97 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 28.02 | 16.67 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.